Sun Pharma Surpasses SBI in Market Valuation

Subscribe to GoodReturns

Drug major Sun Pharmaceutical Industries on Tuesday surpassed SBI, country's largest public sector lender, in terms of market valuation.

Sun Pharma's market capitalisation (m-cap) increased to Rs 2,15,394.82 crore, following over one per cent rally in the stock at the BSE, overtaking SBI whose valuation stood at Rs 2,09,488.41 crore during the afternoon trade.

Sun Pharma Surpasses SBI in Market Valuation

SBI's scrip was trading 0.48% lower at Rs 280.30.

With this, Sun Pharma now stands at 8th position in the list of top-10 most valued companies in terms of their market capitalisation, followed by SBI at ninth place.

TCS is the most valued Indian company with a market cap of Rs 5,04,068.85 crore, followed by RIL, ITC, ONGC, HDFC Bank, Infosys, CIL, Sun Pharma, SBI and HDFC.

Market capitalisation of a listed company corresponds to the cumulative market price of all its shares. This figure changes daily with change in stock price.

PTI

Read more about: sun pharma, sbi
Please Wait while comments are loading...
Company Search
Enter the first few characters of the company's name or the NSE symbol or BSE code and click 'Go'

Thousands of Goodreturn readers receive our evening newsletter.
Have you subscribed?